Loading
Arno Therapeutics, Inc Stock: price and insider trades · United States
US·Mcap US$4.9k
No insider purchase over the last 90 days. The latest was filed 14 Jan 2016.
Arno Therapeutics, Inc: what insiders have been doing
Arno Therapeutics, Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). Arno Therapeutics, Inc has had no insider filing for more than a year; the last one goes back to 14 January 2016.
In the same market, recent insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
8 ops. · all time
Sell Volume
n/a
n/a
Financial data
as of FY 2015FY ended December 2015 · cache
US$0.00
Analyst consensus
Income statement
EBITDA-US$11.1M
Net income-US$9.9M0.0% margin
Valuation
Beta-30.34
Profitability & ownership
ROA-500.0%
% insiders0.0%
% institutions2.7%
Last declaration on 14 January 2016
Declarations8 total
707,868 sharesCommon StockSEC:0000914190-16-000516:0
Canonical exit: 11 Apr 2016 (T+90)
533,208 sharesCommon StockSEC:0000914190-16-000516:1
Canonical exit: 11 Apr 2016 (T+90)
206,986 sharesCommon StockSEC:0000914190-16-000516:2
Canonical exit: 11 Apr 2016 (T+90)
1,448,062 sharesCommon StockSEC:0000914190-16-000517:0
Canonical exit: 11 Apr 2016 (T+90)
714,285 sharesCommon StockSEC:0000914190-16-000517:1
Canonical exit: 11 Apr 2016 (T+90)
362,015 sharesCommon StockSEC:0000914190-16-000518:0
Canonical exit: 11 Apr 2016 (T+90)
144,806 sharesCommon StockSEC:0000914190-16-000519:0
Canonical exit: 11 Apr 2016 (T+90)
2,876,633 sharesCommon StockSEC:0000914190-16-000520:0
Canonical exit: 11 Apr 2016 (T+90)
8 of 8 declarations
About Arno Therapeutics, Inc
Arno Therapeutics, Inc is a company focused on developing innovative cancer treatments. It is listed on the XNAS market.
